Analyst Insights - Digital Health Posts
Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.
VC-Funding for Medical Imaging AI Companies Tops $2.6 Billion
08th March 2021 – Capital investment for companies developing medical imaging AI applications has totalled more than $2.6 billion since 2014. Despite the COVID-19 global pandemic, almost a quarter of the total funding ($592.3 million) was raised last year (2020) alone, and most of this investment was raised by companies from China.
Signify Premium Insight: Fujifilm and Hitachi – The Pieces of a Puzzle
Signify Premium Insights Subscription Required
March 4th 2021 – Fujifilm has announced that its acquisition of Hitachi’s imaging division is set to close at the end of March. This Insight looks at what Fujifilm is actually getting, and how it might help its strategy going forward.
EHR Q4 2020 Financials Highlight Mixed Regional Trends in 2020
4th March 2021 – With Q4 2020 revenue data now published for several leading EHR vendors, Signify Research compares its 2020 estimates versus these public financials.
Signify Premium Insight: The Options for Watson
Signify Premium Insights Subscription Required
March 2nd 2021 – IBM, and its plan to use AI to solve some of the biggest problems in healthcare, made headlines when it first announced its Watson Health division. Now however, the company is reportedly looking to sell the unit. This insight considers what’s changed to assess the rumours.
AI in Drug Development & Clinical Trials Market to Reach $3.0 Billion by 2024
25th February 2021 – The world market for AI used in drug development and clinical trials is set to reach almost $3.0 billion by 2024. This is according to a new report from Signify Research, an independent supplier of market intelligence and consultancy to the global healthcare technology industry.